Keith Michael Gottesdiener, CEO & President at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 20,230 shares at $30.01 ($607K) on 2019-01-18, disclosed to the SEC on 2019-01-22.
Open-market sale of $607k RYTM by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.01 | 10,115 | $304K | 50.0% |
| 2 | $30.01 | 10,115 | $304K | 50.0% |
| Total | $30.01 avg | 20,230 | $607K | 100% |
| Filing → |
| RYTM | SELL | 2019-02-28 | $128K | — | Filing → |
| RYTM | SELL | 2019-02-20 | $748K | — | Filing → |
| RYTM | SELL | 2019-02-15 | $118K | — | Filing → |